Thoracic Surgery and Oncology Clinic
The UCSF Thoracic Surgery and Oncology Clinic offers state-of-the-art diagnosis and treatment for lung cancer and other conditions related to the lungs, chest and esophagus. Our team of surgeons, medical oncologists and radiation oncologists works together closely to ensure that each patient receives comprehensive care.
Our surgeons are highly skilled in minimally invasive techniques, including robot-assisted surgery, performed at UCSF since 2016. After surgery, patients receive care in our Thoracic Enhanced Recovery After Surgery Program. Bringing together a team of experts from different disciplines, this program follows a protocol before, during and after chest surgery that has been shown to decrease complications and improve results.
Our medical oncologists provide leading-edge treatments that are generally more effective and easier on patients than many traditional cancer therapies. These include targeted therapies, which attack the cancer without damaging healthy cells, and immunotherapy, which harnesses the patient's own immune system to fight the cancer. In some cases, we also perform genetic testing of tumors, which can help us choose the most effective treatment plan for individual patients.
During treatment, our patients have access to many support services designed to enhance their overall wellness, such as smoking cessation classes and support groups, nutrition education, mental health care and integrative therapies.
Alongside our commitment to providing excellent patient care, our team is dedicated to finding safer and more effective cancer treatments through research. Interested patients may have the option to receive promising experimental treatments by joining a clinical trial.
Learn more about clinical trials and how they work.
Our locations
Our team
Lung Cancer Mutations and Treatment Advances
KRAS is one of the common genetic mutations that cause lung cancer. Watch leading researchers discuss new treatments on the horizon that target this mutation.
Clinical trials
Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic A...
ORR based on the proportion of patients with best overall response (BOR) of confirmed partial response (PR) or complete response (CR) from the time of study treatment initiation until disease progression as determined by IRR using...
Recruiting
U.S. News rankings
-
Among the top hospitals in the nation
-
Best in Northern California for cancer care (tie)
-
Best in Northern California for pulmonology & lung surgery
-
Rated high-performing hospital for lung cancer surgery
Accreditations & memberships
-
National Cancer Institute
The National Cancer Institute has designated UCSF a comprehensive cancer center, its highest ranking. This designation is awarded to centers that demonstrate scientific excellence and the ability to conduct cancer research across many disciplines.
-
Commission on Cancer
UCSF's cancer programs have been accredited by the American College of Surgeons' Commission on Cancer (CoC) since 1933. The CoC is a consortium of groups dedicated to improving cancer patients' survival and quality of life via research, education and better medical care.
-
National Comprehensive Cancer Network
UCSF is a founding member of the National Comprehensive Cancer Network, an alliance of the world’s top cancer centers. The network brings together leaders in treatment and research to improve the quality, effectiveness and efficiency of cancer care.
Support services
Plan your visit
What to Bring
- Photo I.D.
- Health insurance card
- Insurance authorization, if required
- Doctor's referral, if required
- Recent test results related to your condition
- List of your medications, including dosages, plus any you're allergic to
- List of questions you may have
- Device or paper for taking notes
Related clinics
Our research initiatives
-
UCSF Helen Diller Family Comprehensive Cancer Center Research
UCSF is home to a range of research initiatives aimed at improving outcomes for cancer patients everywhere. This includes research on topics such as immunotherapy, BRCA mutations and molecular diagnostic testing.